Universal Influenza Vaccine Technology Landscape

The Landscape is a database of novel vaccine candidates designed to provide broader and more durable protection against circulating and pandemic influenza viruses, compared with current strain-specific seasonal influenza vaccines. CIDRAP is developing the landscape with support from the Global Funders Consortium for Universal Influenza Vaccine Development.

Tracker

Vaccine Candidates 114 Vaccine Candidates
Vaccine in clinical trials 22 Vaccines in Clinical Trials
Developers 105 Developers
Platforms 6 Platforms
Preclinical 92
Phase 1 12
Phase 2 7
Phase 3 3
Approved 0

Database

Previous Next
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Platform

Recombinant proteins

22
Vaccines in
Preclinical
3
Vaccines in
Phase 1
1
Vaccines in
Phase 2
1
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Recombinant influenza virus-based

7
Vaccines in
Preclinical
2
Vaccines in
Phase 1
2
Vaccines in
Phase 2
0
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Virus-vectored

14
Vaccines in
Preclinical
1
Vaccines in
Phase 1
3
Vaccines in
Phase 2
0
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Virus-like particles (VLP)

17
Vaccines in
Preclinical
1
Vaccines in
Phase 1
0
Vaccines in
Phase 2
1
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Non-VLP nanoparticles

18
Vaccines in
Preclinical
2
Vaccines in
Phase 1
1
Vaccines in
Phase 2
1
Vaccines in
Phase 3
0
Vaccines in
Approved
Platform

Nucleic acid-based

14
Vaccines in
Preclinical
3
Vaccines in
Phase 1
0
Vaccines in
Phase 2
0
Vaccines in
Phase 3
0
Vaccines in
Approved